Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis

Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis. Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid profile. ApoC-II mimetics reverse hypertriglyceridemia and ApoE-based peptides such as Ac-hE18A-NH2 reduce cholesterol an...

Descripción completa

Detalles Bibliográficos
Autores principales: Benitez Amaro, Aleyda, Solanelles Curco, Angels, Garcia, Eduardo, Julve, Josep, Rives, Jose, Benitez, Sonia, Llorente Cortes, Vicenta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396846/
https://www.ncbi.nlm.nih.gov/pubmed/34441867
http://dx.doi.org/10.3390/jcm10163571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396846/
https://www.ncbi.nlm.nih.gov/pubmed/34441867
http://dx.doi.org/10.3390/jcm10163571

Ejemplares similares